Ovarian Cancer Maintenance Therapy With Bevacizumab

Clinical Pearls

Robert A. Burger, MD, Professor, Department of Surgical Oncology, Director, Women’s Cancer Center, Fox Chase Cancer Center, discusses ovarian cancer maintenance with bevacizumab.

• In frontline trials, bevacizumab was administered with a maximum number of treatment cycles beyond chemotherapy
• In second-line trials, maintenance therapy was continued until disease progression